Related Experiment Video
Updated: Feb 17, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.3K
Immunotherapy advances in pleural mesothelioma
Annie L Zhang1,2, Melinda L Hsu3,2
1University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
Therapeutic Advances in Medical Oncology
|February 16, 2026
Summary
Immunotherapy, including immune checkpoint inhibitors, offers new hope for mesothelioma patients. This approach is now a key treatment for pleural mesothelioma and benefits those with relapsed or refractory disease.
Area of Science:
- Oncology
- Immunology
Background:
- Mesothelioma is a rare cancer with a historically poor prognosis.
- Therapeutic options for mesothelioma have been limited until recently.
- Immune checkpoint inhibitors represent a significant advancement.
Purpose of the Study:
- To review key immunotherapy trials for mesothelioma.
- To discuss challenges in applying immunotherapy for mesothelioma.
- To explore future research directions in mesothelioma immunotherapy.
Main Methods:
- Literature review of scientific articles on mesothelioma immunotherapy.
- Analysis of clinical trial data.
- Discussion of therapeutic challenges and future research.
Main Results:
- Immunotherapy is a cornerstone of first-line treatment for pleural mesothelioma.
- Immunotherapy provides clinical benefit for relapsed or refractory mesothelioma patients.
- Significant challenges remain in the application of immunotherapy.
Conclusions:
- Immunotherapy has transformed mesothelioma treatment paradigms.
- Further research is needed to overcome current challenges and optimize immunotherapy efficacy.
- Future research should focus on novel immunotherapy strategies for mesothelioma.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
01:30Pleural Disorders: Types and Brief Description
734
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
734
01:30Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K